TET2 and acute myeloid leukemia: Mutations in TET2 in HSPCs have been proposed to cause DNA damage and activation of the cyclic GMP–AMP synthase‐stimulator of IFN genes pathway, which induces the production of inflammatory factors that promote AML development and human age‐related clonal hematopoiesis [333].